Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease - Concepedia

Concepedia

Publication | Closed Access

Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease

36

Citations

25

References

2022

Year

Antoine Meyer, Anke Neumann, Jérôme Drouin, Alain Weill, Franck Carbonnel, Rosemary Dray‐Spira

Annals of Internal Medicine

Abstract

None.

References

	Year	Citations

Page 1